Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference The new mini-textbook by Kamps & Hoffmann PDF, 110 pages

Breast Cancer

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 74 articles: HTML format Text format

Single Articles

March 2020
1. YI Y, Chen D, Ao J, Zhang W, et al
   Transcriptional suppression of AMPKalpha1 promotes breast cancer metastasis upon oncogene activation.
   Proc Natl Acad Sci U S A. 2020 Mar 19. pii: 1914786117.
   PubMed     Text format     Abstract available
   
   
   
2. KESAVAN R, Fromel T, Zukunft S, Laban H, et al
   Cyp2c44 regulates prostaglandin synthesis, lymphangiogenesis, and metastasis in a mouse model of breast cancer.
   Proc Natl Acad Sci U S A. 2020 Mar 2. pii: 1921381117.
   PubMed     Text format     Abstract available
   
   
   January 2020
3. GALLAGHER FA, Woitek R, McLean MA, Gill AB, et al
   Imaging breast cancer using hyperpolarized carbon-13 MRI.
   Proc Natl Acad Sci U S A. 2020 Jan 21. pii: 1913841117.
   PubMed     Text format     Abstract available
   
   
   
4. BLOCKHUYS S, Zhang X, Wittung-Stafshede P
   Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration.
   Proc Natl Acad Sci U S A. 2020 Jan 13. pii: 1910722117.
   PubMed     Text format     Abstract available
   
   
   December 2019
5. GREENE KS, Lukey MJ, Wang X, Blank B, et al
   SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis.
   Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1911954116.
   PubMed     Text format     Abstract available
   
   
   
6. FU X, Pereira R, De Angelis C, Veeraraghavan J, et al
   FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer.
   Proc Natl Acad Sci U S A. 2019 Dec 11. pii: 1911584116.
   PubMed     Text format     Abstract available
   
   
   
7. BANERJEE S, Wei T, Wang J, Lee JJ, et al
   Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression.
   Proc Natl Acad Sci U S A. 2019;116:24881-24891.
   PubMed     Text format     Abstract available
   
   
   November 2019
8. HJELMELAND AB, Patel RP
   SOD2 acetylation and deacetylation: Another tale of Jekyll and Hyde in cancer.
   Proc Natl Acad Sci U S A. 2019;116:23376-23378.
   PubMed     Text format    
   
   
   
9. YOU S, Barkalifa R, Chaney EJ, Tu H, et al
   Label-free visualization and characterization of extracellular vesicles in breast cancer.
   Proc Natl Acad Sci U S A. 2019 Nov 15. pii: 1909243116.
   PubMed     Text format     Abstract available
   
   
   
10. RODRIGUES-FERREIRA S, Nehlig A, Moindjie H, Monchecourt C, et al
    Improving breast cancer sensitivity to paclitaxel by increasing aneuploidy.
    Proc Natl Acad Sci U S A. 2019 Nov 4. pii: 1910824116.
    PubMed     Text format     Abstract available
    
    
    October 2019
11. KREUZALER P, Clarke MA, Brown EJ, Wilson CH, et al
    Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modeling.
    Proc Natl Acad Sci U S A. 2019 Oct 14. pii: 1903485116.
    PubMed     Text format     Abstract available
    
    
    
12. HAGERLING C, Gonzalez H, Salari K, Wang CY, et al
    Immune effector monocyte-neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer.
    Proc Natl Acad Sci U S A. 2019 Oct 7. pii: 1907660116.
    PubMed     Text format     Abstract available
    
    
    
13. HE C, Danes JM, Hart PC, Zhu Y, et al
    SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancer.
    Proc Natl Acad Sci U S A. 2019 Oct 7. pii: 1902308116.
    PubMed     Text format     Abstract available
    
    
    May 2019
14. MOROTTI M, Bridges E, Valli A, Choudhry H, et al
    Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer.
    Proc Natl Acad Sci U S A. 2019 May 31. pii: 1818521116.
    PubMed     Text format     Abstract available
    
    
    
15. 
    Correction for Kroger et al., Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.
    Proc Natl Acad Sci U S A. 2019 May 28. pii: 1907473116.
    PubMed     Text format    
    
    
    
16. BAI J, Wu K, Cao MH, Yang Y, et al
    SCF(FBXO22) targets HDM2 for degradation and modulates breast cancer cell invasion and metastasis.
    Proc Natl Acad Sci U S A. 2019 May 28. pii: 1820990116.
    PubMed     Text format     Abstract available
    
    
    April 2019
17. VERMA S, Yeddula N, Soda Y, Zhu Q, et al
    BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling.
    Proc Natl Acad Sci U S A. 2019;116:7363-7370.
    PubMed     Text format     Abstract available
    
    
    
18. SHANBHAG V, Jasmer-McDonald K, Zhu S, Martin AL, et al
    ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis.
    Proc Natl Acad Sci U S A. 2019;116:6836-6841.
    PubMed     Text format     Abstract available
    
    
    March 2019
19. ZHANG J, Goliwas KF, Wang W, Taufalele PV, et al
    Energetic regulation of coordinated leader-follower dynamics during collective invasion of breast cancer cells.
    Proc Natl Acad Sci U S A. 2019 Mar 28. pii: 1809964116.
    PubMed     Text format     Abstract available
    
    
    
20. CROW M, Lim N, Ballouz S, Pavlidis P, et al
    Predictability of human differential gene expression.
    Proc Natl Acad Sci U S A. 2019;116:6491-6500.
    PubMed     Text format     Abstract available
    
    
    
21. KROGER C, Afeyan A, Mraz J, Eaton EN, et al
    Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.
    Proc Natl Acad Sci U S A. 2019 Mar 25. pii: 1812876116.
    PubMed     Text format     Abstract available
    
    
    
22. 
    Correction for Blasco-Benito et al., Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.
    Proc Natl Acad Sci U S A. 2019 Mar 18. pii: 1903209116.
    PubMed     Text format    
    
    
    February 2019
23. CHUANG PK, Hsiao M, Hsu TL, Chang CF, et al
    Signaling pathway of globo-series glycosphingolipids and beta1,3-galactosyltransferase V (beta3GalT5) in breast cancer.
    Proc Natl Acad Sci U S A. 2019;116:3518-3523.
    PubMed     Text format     Abstract available
    
    
    
24. ONDECK MG, Kumar A, Placone JK, Plunkett CM, et al
    Dynamically stiffened matrix promotes malignant transformation of mammary epithelial cells via collective mechanical signaling.
    Proc Natl Acad Sci U S A. 2019;116:3502-3507.
    PubMed     Text format     Abstract available
    
    
    
25. JIA D, Lu M, Jung KH, Park JH, et al
    Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
    Proc Natl Acad Sci U S A. 2019;116:3909-3918.
    PubMed     Text format     Abstract available
    
    
    
26. SLEDGE GW
    Targeting CXCR4-induced desmoplasia to improve checkpoint inhibition in breast cancer.
    Proc Natl Acad Sci U S A. 2019 Feb 22. pii: 1900368116.
    PubMed     Text format    
    
    
    
27. VOUTOURI C, Kirkpatrick ND, Chung E, Mpekris F, et al
    Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategies.
    Proc Natl Acad Sci U S A. 2019;116:2662-2671.
    PubMed     Text format     Abstract available
    
    
    
28. LI X, Gruosso T, Zuo D, Omeroglu A, et al
    Infiltration of CD8(+) T cells into tumor cell clusters in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2019 Feb 7. pii: 1817652116.
    PubMed     Text format     Abstract available
    
    
    
29. BLASCO-BENITO S, Moreno E, Seijo-Vila M, Tundidor I, et al
    Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.
    Proc Natl Acad Sci U S A. 2019 Feb 7. pii: 1815034116.
    PubMed     Text format     Abstract available
    
    
    
30. KUBLI SP, Bassi C, Roux C, Wakeham A, et al
    AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer.
    Proc Natl Acad Sci U S A. 2019 Feb 7. pii: 1815126116.
    PubMed     Text format     Abstract available
    
    
    January 2019
31. CHEN IX, Chauhan VP, Posada J, Ng MR, et al
    Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer.
    Proc Natl Acad Sci U S A. 2019 Jan 30. pii: 1815515116.
    PubMed     Text format     Abstract available
    
    
    
32. KOBOLD S
    Innate and adaptive immunity combined for cancer treatment.
    Proc Natl Acad Sci U S A. 2019;116:1087-1088.
    PubMed     Text format    
    
    
    
33. ZHANG S, Zhang H, Ghia EM, Huang J, et al
    Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody.
    Proc Natl Acad Sci U S A. 2019 Jan 8. pii: 1816262116.
    PubMed     Text format     Abstract available
    
    
    December 2018
34. TOMINAGA K, Minato H, Murayama T, Sasahara A, et al
    Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.
    Proc Natl Acad Sci U S A. 2018 Dec 26. pii: 1806851116.
    PubMed     Text format     Abstract available
    
    
    
35. BOCCI F, Gearhart-Serna L, Boareto M, Ribeiro M, et al
    Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.
    Proc Natl Acad Sci U S A. 2018 Dec 26. pii: 1815345116.
    PubMed     Text format     Abstract available
    
    
    
36. KAPLANOV I, Carmi Y, Kornetsky R, Shemesh A, et al
    Blocking IL-1beta reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation.
    Proc Natl Acad Sci U S A. 2018 Dec 13. pii: 1812266115.
    PubMed     Text format     Abstract available
    
    
    
37. TOKUYAMA M, Kong Y, Song E, Jayewickreme T, et al
    ERVmap analysis reveals genome-wide transcription of human endogenous retroviruses.
    Proc Natl Acad Sci U S A. 2018;115:12565-12572.
    PubMed     Text format     Abstract available
    
    
    
38. LIU C, Sun L, Yang J, Liu T, et al
    FSIP1 regulates autophagy in breast cancer.
    Proc Natl Acad Sci U S A. 2018 Dec 3. pii: 1809681115.
    PubMed     Text format     Abstract available
    
    
    November 2018
39. MATSUNUMA R, Chan DW, Kim BJ, Singh P, et al
    DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer.
    Proc Natl Acad Sci U S A. 2018 Nov 29. pii: 1810598115.
    PubMed     Text format     Abstract available
    
    
    October 2018
40. SUN XX, Chen Y, Su Y, Wang X, et al
    SUMO protease SENP1 deSUMOylates and stabilizes c-Myc.
    Proc Natl Acad Sci U S A. 2018;115:10983-10988.
    PubMed     Text format     Abstract available
    
    
    
41. LIANG W, Li Q, Ferrara N
    Metastatic growth instructed by neutrophil-derived transferrin.
    Proc Natl Acad Sci U S A. 2018;115:11060-11065.
    PubMed     Text format     Abstract available
    
    
    September 2018
42. REESE JM, Bruinsma ES, Nelson AW, Chernukhin I, et al
    ERbeta-mediated induction of cystatins results in suppression of TGFbeta signaling and inhibition of triple-negative breast cancer metastasis.
    Proc Natl Acad Sci U S A. 2018 Sep 26. pii: 1807751115.
    PubMed     Text format     Abstract available
    
    
    
43. GURYEV EL, Volodina NO, Shilyagina NY, Gudkov SV, et al
    Radioactive ((90)Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer.
    Proc Natl Acad Sci U S A. 2018;115:9690-9695.
    PubMed     Text format     Abstract available
    
    
    
44. LAN J, Lu H, Samanta D, Salman S, et al
    Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment.
    Proc Natl Acad Sci U S A. 2018 Sep 21. pii: 1809695115.
    PubMed     Text format     Abstract available
    
    
    
45. CHU B, He A, Tian Y, He W, et al
    Photoaffinity-engineered protein scaffold for systematically exploring native phosphotyrosine signaling complexes in tumor samples.
    Proc Natl Acad Sci U S A. 2018;115:E8863-E8872.
    PubMed     Text format     Abstract available
    
    
    August 2018
46. ARVANITIS CD, Askoxylakis V, Guo Y, Datta M, et al
    Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption.
    Proc Natl Acad Sci U S A. 2018 Aug 27. pii: 1807105115.
    PubMed     Text format     Abstract available
    
    
    
47. GRITHER WR, Longmore GD
    Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain.
    Proc Natl Acad Sci U S A. 2018;115:E7786-E7794.
    PubMed     Text format     Abstract available
    
    
    
48. DATTA S, Misra SK, Saha ML, Lahiri N, et al
    Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells.
    Proc Natl Acad Sci U S A. 2018;115:8087-8092.
    PubMed     Text format     Abstract available
    
    
    
49. FOULDS CE
    Disrupting a negative feedback loop drives endocrine therapy-resistant breast cancer.
    Proc Natl Acad Sci U S A. 2018 Aug 6. pii: 1811263115.
    PubMed     Text format    
    
    
    July 2018
50. REN C, Zhang G, Han F, Fu S, et al
    Spatially constrained tandem bromodomain inhibition bolsters sustained repression of BRD4 transcriptional activity for TNBC cell growth.
    Proc Natl Acad Sci U S A. 2018;115:7949-7954.
    PubMed     Text format     Abstract available
    
    
    
51. WANG B, Li D, Kovalchuk I, Apel IJ, et al
    miR-34a directly targets tRNAi(Met) precursors and affects cellular proliferation, cell cycle, and apoptosis.
    Proc Natl Acad Sci U S A. 2018;115:7392-7397.
    PubMed     Text format     Abstract available
    
    
    
52. XIAO T, Li W, Wang X, Xu H, et al
    Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.
    Proc Natl Acad Sci U S A. 2018 Jul 9. pii: 1722617115.
    PubMed     Text format     Abstract available
    
    
    
53. LEE JJ, van de Ven RAH, Zaganjor E, Ng MR, et al
    Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3.
    Proc Natl Acad Sci U S A. 2018;115:7057-7062.
    PubMed     Text format     Abstract available
    
    
    June 2018
54. MITTAL S, Yeh K, Leslie LS, Kenkel S, et al
    Simultaneous cancer and tumor microenvironment subtyping using confocal infrared microscopy for all-digital molecular histopathology.
    Proc Natl Acad Sci U S A. 2018;115:E5651-E5660.
    PubMed     Text format     Abstract available
    
    
    
55. SUN X, Wang X, Tang Z, Grivainis M, et al
    Transcription factor profiling reveals molecular choreography and key regulators of human retrotransposon expression.
    Proc Natl Acad Sci U S A. 2018;115:E5526-E5535.
    PubMed     Text format     Abstract available
    
    
    
56. DE SEMIR D, Bezrookove V, Nosrati M, Dar AA, et al
    PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.
    Proc Natl Acad Sci U S A. 2018 Jun 4. pii: 1804779115.
    PubMed     Text format     Abstract available
    
    
    May 2018
57. ROY B, Venkatachalapathy S, Ratna P, Wang Y, et al
    Laterally confined growth of cells induces nuclear reprogramming in the absence of exogenous biochemical factors.
    Proc Natl Acad Sci U S A. 2018;115:E4741-E4750.
    PubMed     Text format     Abstract available
    
    
    
58. SEO A, Steinberg-Shemer O, Unal S, Casadei S, et al
    Mechanism for survival of homozygous nonsense mutations in the tumor suppressor gene BRCA1.
    Proc Natl Acad Sci U S A. 2018;115:5241-5246.
    PubMed     Text format     Abstract available
    
    
    
59. LAI X, Stiff A, Duggan M, Wesolowski R, et al
    Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors.
    Proc Natl Acad Sci U S A. 2018 May 7. pii: 1721559115.
    PubMed     Text format     Abstract available
    
    
    April 2018
60. NAIR P, Vilcek J
    Profile of Alexander Y. Rudensky, winner of the 2018 Vilcek Prize in Biomedical Science.
    Proc Natl Acad Sci U S A. 2018;115:4301-4304.
    PubMed     Text format    
    
    
    
61. VEGA-RUBIN-DE-CELIS S, Zou Z, Fernandez AF, Ci B, et al
    Increased autophagy blocks HER2-mediated breast tumorigenesis.
    Proc Natl Acad Sci U S A. 2018;115:4176-4181.
    PubMed     Text format     Abstract available
    
    
    
62. ZHAO L, Huang S, Mei S, Yang Z, et al
    Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.
    Proc Natl Acad Sci U S A. 2018;115:E3673-E3681.
    PubMed     Text format     Abstract available
    
    
    March 2018
63. KE H, Zhao L, Zhang H, Feng X, et al
    Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3.
    Proc Natl Acad Sci U S A. 2018 Mar 26. pii: 1714573115.
    PubMed     Text format     Abstract available
    
    
    
64. FLOROS KV, Lochmann TL, Hu B, Monterrubio C, et al
    Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy.
    Proc Natl Acad Sci U S A. 2018;115:E2594-E2603.
    PubMed     Text format     Abstract available
    
    
    February 2018
65. HASHIMOTO K, Ochi H, Sunamura S, Kosaka N, et al
    Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.
    Proc Natl Acad Sci U S A. 2018;115:2204-2209.
    PubMed     Text format     Abstract available
    
    
    January 2018
66. THU KL, Silvester J, Elliott MJ, Ba-Alawi W, et al
    Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2018 Jan 29. pii: 1719577115.
    PubMed     Text format     Abstract available
    
    
    
67. SAMANTA D, Park Y, Ni X, Li H, et al
    Chemotherapy induces enrichment of CD47(+)/CD73(+)/PDL1(+) immune evasive triple-negative breast cancer cells.
    Proc Natl Acad Sci U S A. 2018 Jan 24. pii: 1718197115.
    PubMed     Text format     Abstract available
    
    
    
68. DEVIGNES CS, Aslan Y, Brenot A, Devillers A, et al
    HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice.
    Proc Natl Acad Sci U S A. 2018 Jan 16. pii: 1718009115.
    PubMed     Text format     Abstract available
    
    
    December 2017
69. DOHERTY MR, Cheon H, Junk DJ, Vinayak S, et al
    Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1713728114.
    PubMed     Text format     Abstract available
    
    
    November 2017
70. BEAUSANG JF, Wheeler AJ, Chan NH, Hanft VR, et al
    T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire.
    Proc Natl Acad Sci U S A. 2017 Nov 14. pii: 201713863.
    PubMed     Text format     Abstract available
    
    
    
71. 
    Correction for Sansone et al., Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.
    Proc Natl Acad Sci U S A. 2017 Nov 13. pii: 201718630.
    PubMed     Text format    
    
    
    October 2017
72. BASUDHAR D, Glynn SA, Greer M, Somasundaram V, et al
    Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.
    Proc Natl Acad Sci U S A. 2017 Oct 27. pii: 201709119.
    PubMed     Text format     Abstract available
    
    
    
73. SANSONE P, Savini C, Kurelac I, Chang Q, et al
    Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.
    Proc Natl Acad Sci U S A. 2017;114:E9066-E9075.
    PubMed     Text format     Abstract available
    
    
    September 2017
74. HE F, Chiou AE, Loh HC, Lynch M, et al
    Multiscale characterization of the mineral phase at skeletal sites of breast cancer metastasis.
    Proc Natl Acad Sci U S A. 2017 Sep 18. pii: 201708161.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: